249 related articles for article (PubMed ID: 23280518)
1. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss.
Doan V; Kleindienst AM; McMahon EJ; Long BR; Matsushima GK; Taylor LC
J Neurosci Res; 2013 Mar; 91(3):363-73. PubMed ID: 23280518
[TBL] [Abstract][Full Text] [Related]
2. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
3. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
4. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
5. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
6. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
7. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
8. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
9. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
10. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
11. Cuprizone-induced demyelination in CNP::GFP transgenic mice.
Silvestroff L; Bartucci S; Soto E; Gallo V; Pasquini J; Franco P
J Comp Neurol; 2010 Jun; 518(12):2261-83. PubMed ID: 20437527
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.
Hoyos HC; Rinaldi M; Mendez-Huergo SP; Marder M; Rabinovich GA; Pasquini JM; Pasquini LA
Neurobiol Dis; 2014 Feb; 62():441-55. PubMed ID: 24184798
[TBL] [Abstract][Full Text] [Related]
13. Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
Pfeifenbring S; Nessler S; Wegner C; Stadelmann C; Brück W
J Neuropathol Exp Neurol; 2015 Aug; 74(8):756-66. PubMed ID: 26115190
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
Franco PG; Silvestroff L; Soto EF; Pasquini JM
Exp Neurol; 2008 Aug; 212(2):458-67. PubMed ID: 18572165
[TBL] [Abstract][Full Text] [Related]
15. p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice.
Copray JC; Küst BM; Mantingh-Otter I; Boddeke HW
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):600-9. PubMed ID: 16281908
[TBL] [Abstract][Full Text] [Related]
16. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
[TBL] [Abstract][Full Text] [Related]
17. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination.
Mason JL; Jones JJ; Taniike M; Morell P; Suzuki K; Matsushima GK
J Neurosci Res; 2000 Aug; 61(3):251-62. PubMed ID: 10900072
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
Skripuletz T; Miller E; Grote L; Gudi V; Pul R; Voss E; Skuljec J; Moharregh-Khiabani D; Trebst C; Stangel M
Brain Behav Immun; 2011 Nov; 25(8):1592-606. PubMed ID: 21635946
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Mason JL; Toews A; Hostettler JD; Morell P; Suzuki K; Goldman JE; Matsushima GK
Am J Pathol; 2004 May; 164(5):1673-82. PubMed ID: 15111314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
